Yu S - Search Results

1

Impact of the Xinsorb Scaffold-Related Parameters on Platelet Reactivity in Patients with Single De Novo Coronary Artery Lesions Undergoing Clopidogrel Treatment.

Yu S, Wang M, Yan M, Wang B, Xu Y. Yu S, et al. Anatol J Cardiol. 2023 Jul 3;27(7):408-416. doi: 10.14744/AnatolJCardiol.2023.3071. Epub 2023 Jun 7. Anatol J Cardiol. 2023. PMID: 37288850 Free PMC article.

2

Activation of GPR39 with the agonist TC-G 1008 ameliorates ox-LDL-induced attachment of monocytes to endothelial cells.

Xu Y, Wang M, Xie Y, Jiang Y, Liu M, Yu S, Wang B, Liu Q. Xu Y, et al. Among authors: yu s. Eur J Pharmacol. 2019 Sep 5;858:172451. doi: 10.1016/j.ejphar.2019.172451. Epub 2019 Jun 13. Eur J Pharmacol. 2019. PMID: 31202806

3

Development and validation of a prediction model for in-hospital death in patients with heart failure and atrial fibrillation.

Yan M, Liu H, Xu Q, Yu S, Tang K, Xie Y. Yan M, et al. Among authors: yu s. BMC Cardiovasc Disord. 2023 Oct 11;23(1):505. doi: 10.1186/s12872-023-03521-3. BMC Cardiovasc Disord. 2023. PMID: 37821809 Free PMC article.

4

Dynamic changes in inflammatory responses and 3-year clinical outcomes of XINSORB scaffolds in coronary stenting.

Yu S, Wang M, Yan M, Wang B, Xu Y. Yu S, et al. Cardiovasc Revasc Med. 2024 Apr;61:70-81. doi: 10.1016/j.carrev.2023.10.020. Epub 2023 Nov 2. Cardiovasc Revasc Med. 2024. PMID: 37949719

5

MiR-495-3p promotes cardiac hypertrophy by targeting Pum2.

Yu S, Wang M, Xie Y, Wang B, Xu Y. Yu S, et al. Cell Mol Biol (Noisy-le-grand). 2024 Sep 8;70(8):116-120. doi: 10.14715/cmb/2024.70.8.15. Cell Mol Biol (Noisy-le-grand). 2024. PMID: 39262254

6

Influence of Different Obstetric Factors on Early Postpartum Pelvic Floor Function in Primiparas After Vaginal Delivery.

Chi X, Yu S, Zhu K, Chen Y, Chu Y, Chen X. Chi X, et al. Among authors: yu s. Int J Womens Health. 2023 Jan 22;15:81-90. doi: 10.2147/IJWH.S390626. eCollection 2023. Int J Womens Health. 2023. PMID: 36713132 Free PMC article.

7

LncRNA TUG1 Exacerbates Myocardial Fibrosis in Diabetic Cardiomyopathy by Modulating the microRNA-145a-5p/Cfl2 Axis.

Wang K, Lin Y, Shen H, Yu S, Xu J. Wang K, et al. Among authors: yu s. J Cardiovasc Pharmacol. 2023 Mar 1;81(3):192-202. doi: 10.1097/FJC.0000000000001391. J Cardiovasc Pharmacol. 2023. PMID: 36450139

8

Discovery of an Ultralong-acting Nondepolarizing Neuromuscular Blocker That Displays Short Onset Time and On-Demand Rapid Reversal by a Biocompatible Antagonist.

Yang J, Wu Y, Liu YY, Yu SB, Feng K, Wang H, Zhou W, Ma D, Zhao G, Zhang J, Zhang DW, Li ZT. Yang J, et al. Among authors: yu sb. J Med Chem. 2025 Jan 24. doi: 10.1021/acs.jmedchem.4c03022. Online ahead of print. J Med Chem. 2025. PMID: 39854499

9

MiRNA-223-5p inhibits hypoxia-induced apoptosis of BMSCs and promotes repair in Legg-Calvé-Perthes disease by targeting CHAC2 and activating the Wnt/β-catenin signaling pathway.

Yang J, Zhang T, Zhu X, He Z, Jiang X, Yu S, Gu H. Yang J, et al. Among authors: yu s. PLoS One. 2025 Jan 24;20(1):e0315230. doi: 10.1371/journal.pone.0315230. eCollection 2025. PLoS One. 2025. PMID: 39854306

10

Nanomaterials-Induced Pyroptosis: Advancing Novel Therapeutic Pathways in Nanomedicine.

Yu S, Zhang Y, Zhou Z, Li J, Meng H. Yu S, et al. Small Methods. 2025 Jan 24:e2401290. doi: 10.1002/smtd.202401290. Online ahead of print. Small Methods. 2025. PMID: 39853957 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,974 results

Search Page

Filters